II) Medical Education: 1984, Doctor of Medicine from the Oregon Health and Sciences University School of Medicine, Portland, Oregon.

III) Postgraduate Education:
1984-88. General Psychiatry internship and residency at Tripler Army Medical Center, Honolulu, Hawaii.
1990-91. Consultation-Liaison fellowship at Walter Reed Army Medical Center, Washington, DC.
Honors Received:
1987, Chief Resident
1988, Award for best resident's paper.

IV) Staff and Faculty Positions:
1988-90. Division Psychiatrist, 6th Infantry Division (Light), Ft. Richardson, Alaska.
1991-1998. Assistant Professor of Psychiatry, Uniformed Services University of Health Sciences, F. Hebert School of Medicine, Bethesda, MD.
1991-92. Chief, Psychiatry and Neurology Service, General Leonard Wood Army Community Hospital, Ft. Leonard Wood, MO.
1992-93. Assistant Chief, Psychiatry Consultation-Liaison Service, Walter Reed Army Medical Center, Washington, DC.
1993-1995. Chief, Psychiatry Consultation-Liaison Service, Walter Reed Army Medical Center, Washington, DC.
1993-1995. Training Director, Psychiatry Consultation-Liaison Fellowship, Walter Reed Army Medical Center, Washington, DC.
1995-1996. Clinical Director of Adult Services, Willmar Regional Treatment Center, Willmar, MN.
1996-2001. Medical Director, Willmar Regional Treatment Center, Willmar, MN
1998-2001. Instructor, Rural Health School, University of Minnesota, Duluth, MN
2001-2003. Medical Co-Director, Center for Geriatric Psychiatry, Tuality Forest Grove Hospital, Forest Grove, OR
2001-current. Associate Professor of Psychiatry, Oregon Health and Sciences University, Portland, OR
2003-current. Medical Director, Center for Geriatric Psychiatry, Tuality Forest Grove Hospital, Forest Grove, OR
Awards and Honors Received:
1990, Army Commendation Medal
1992 & 1995, Meritorious Service Medal
1996, Fellow of the Academy of Psychosomatic Medicine
2001, co-author of #1 best selling book for APPI at the 154th Annual APA Meeting, New Orleans, LA
2002, co-author of #1 best selling book for APPI at the 155th Annual APA Meeting, Philadelphia, PA
2003, Fellow of the American Psychiatric Association
2003, co-author of #1 best selling book for APPI at the 156th Annual APA Meeting, San Francisco, CA
2004, co-author of #2 best selling book for APPI at the 157th Annual APA Meeting, New York, NY
2004, Dorfman Journal Paper Award for Best Review Article titled: "Pharmacokinetic Drug Interactions of Morphine, Codeine, and Their Derivatives: Theory and Clinical Reality: Parts I and II", from the Academy of Psychosomatic Medicine (Journal of Psychosomatics).
2005, Peer Physician Awards of "Value Improvement", "Physician Champion", "Bridge Builder/Community Recognition" and "Bright Idea" from Tuality Healthcare Physicians.
2005, co-author of top ten selling book for APPI at the 158th Annual APA Meeting, Atlanta, GA
2005, Psychiatrist/Medical Director of the Year, Behavioral Health Services/Horizon Health Management, Western(Barner) Region.
2006, co-author of chapter of textbook, top selling book for Lippincott, Williams and Wilkins at the 159th Annual APA Meeting, Toronto, Canada
2006, Program of the Year for all Behavioral/Rehabilitation Units of the Year managed by Horizon Health Management (out of 118).
2007, 16th Annual Nancy C.A. Roeske award from the American Psychiatric Association, in recognition for excellence in medical student education.
2007, Dorfman journal paper award for review articles to the Psychosomatics Journal on drug-drug interactions, from the Academy of Psychosomatic Medicine.
2008, Distinguished Fellow of the American Psychiatric Association.
2009, co-author of #1 best selling book for APPI at the 162nd Annual APA Meeting, San Francisco, CA
2009, honorable mention of Dorfman Award for Best Review Article, Psychosomatics Journal, on Pharmacokinetic Drug Interactions of Synthetic Opiates. From the Academy of Psychosomatic Medicine.
2010, regional program of the year for Horizon Health Management

V) Medical Licenses:
1987-1997, California Physician and Surgeon's License
1995-2001, Minnesota Physician and Surgeon's License
1999-current, Oregon Physician and Surgeon's License

VI) Board Certification:
1990, American Board of Psychiatry and Neurology (Psychiatry). Lifetime certification.
2005, American Board of Psychiatry and Neurology, added qualifications in Psychosomatic Medicine. 10-year certification

VII) Professional Organizations:
1983-current, Christian Medical and Dental Society (CMDS)
1984-current, American Psychiatric Association (APA). Fellow of APA, 2003, Distinguished Fellow, 2008.
1985-1995, Association of Military Surgeons of the U.S. (AMSUS)
1993-current, Academy of Psychosomatic Medicine (APM) Fellow of APM, 1996
1993-1995, American Association of General Hospital Psychiatrists (AAGHP)
1994-current, Association of Medicine and Psychiatry (AMP)
2005-current, American Association of Geriatric Psychiatry (AAGP)

VIII) Peer Reviewed Professional Publications:

Original articles/research:

Zeff KN, Armstrong SC, Crandell EO and Folen RA. Characteristics Associated with Psychiatric Readmission in Active-Duty Patients. Hospital and Community Psychiatry 41 (1): 91-93, 1990.
Armstrong SC and Took KJ. Psychiatric Managed Care at a Rural MEDDAC. Military Medicine 158 (11): 713-717, 1993.
Armstrong SC, Cozza KL and Watanabe KS. The Misdiagnosis of Delirium. Psychosomatics 38(5): 433-439, 1997.

Case studies and Commentary:

Armstrong SC, Watters MR and Pearce JW. A case of Nocturnal Gelastic Epilepsy. Neuropsychiatry, Neuropsychology and Behavioral Neurology 3 (3): 213-216, 1990.
Grieger TA, Cozza K and Armstrong S. Treatment of Parkinson's Disease. New England Journal of Medicine 330 (9):643-644, 1994.
Peterson KA, Armstrong SC and Moseley J. Pathological Crying Responsive to Sertraline. Journal of Psychopharmacology 16(4):333, 1996.
Armstrong SC and Schweitzer SM. Delirium Associated with a Combination of Paroxetine and Benztropine. American Journal of Psychiatry, 154(4):581-582, 1997.
Armstrong SC and Stephens JM. Clozaril Levels increased by Fluvoxamine: Potential for Benefit and Side Effects. Journal of Clinical Psychiatry 58(11):499, 1997.
Armstrong SC. Refusal of ECT. American Journal of Psychiatry 156(1):160-161, 1999.

Drug-Drug Interaction Papers:

Armstrong SC, Cozza KL: Consultation-Liaison Psychiatry Drug-Drug Interactions Update. Psychosomatics 40(3):275-276, 1999. (Reviews a review article on CyP450, the pros/cons of selective drug inhibition and citalopram's drug interaction profile.)
Armstrong SC, Cozza KL: Consultation-Liaison Psychiatry Drug-Drug Interactions Update. Psychosomatics 40(5):452-453,1999. (Reviews HIV Drug interactions, and selected interaction studies from a research group in Helsinki, Finland).
Armstrong SC, Cozza KL: Consultation-Liaison Psychiatry Drug-Drug Interactions Update. Psychosomatics 41(1):76-77, 2000. (Reviews Grapefuit Juice, caffeine and smoking interactions with drugs and cytochrome P450).
Armstrong SC, Cozza KL: Consultation-Liaison Psychiatry Drug-Drug Interactions Update. Psychosomatics 41(2):155-156, 2000. (Reviews 2 Internet Drug Interaction programs).
Armstrong SC, Cozza KL, Cole MA: Consultation-Liaison Psychiatry Drug-Drug Interactions update. Psychosomatics 41(4):375-376, 2000. (Reviews St John's Wort interactions and lessons learned from the demise of cisapride).
Armstrong SC, Cozza KL: Consultation-Liaison Psychiatry Drug-Drug Interactions Update. Psychosomatics 41(6):541-543, 2000. (Reviews articles on carbamazepine, oxcarbazepine and pharmacogenetics).
Armstrong SC, Cozza KL: Consultation-Liaison Psychiatry Drug-Drug Interactions Update. Psychosomatics 42(2):157-159, 2001. (Reviews interaction of clozapine and fluvoxamine, problems with thioridazine and mesoridazine and drug interactions with bupropion).
Armstrong SC, Cozza KL: Consultation-Liaison Psychiatry Drug-Drug Interactions Update. Psychosomatics 42(3):371-375, 2001. (Reviews P-glycoprotein interactions, problems with drugs that inhibit and induce enzymes, and an update of DDI with Sildenafil).
Armstrong SC, Cozza KL: Med-Psych Drug-Drug Interactions Update. Psychosomatics 42(5):435-437, 2001. (Reviews ziprasidone and pharmacogenetics).
Armstrong SC, Cozza KL, Oesterheld JR: Med-Psych Drug-Drug Interactions Update. Psychosomatics 43(1):77-81, 2002. (Reviews Cholinesterase Inhibitors, the HMG-CoA Reductase Inhibitors and UGT enzymes).
Armstrong SC, Cozza KL: Med-Psych Drug-Drug Interactions Update. Psychosomatics 43(2):169-170, 2002. (Reviews levomethadyl, loratadine and grapefruit juice with clozapine).
Armstrong SC, Cozza KL, Benedek DM: Med-Psych Drug-Drug Interactions Update. Psychosomatics 43(3): 245-247, 2002. (Reviews medico-legal issues of DDI).
Armstrong SC, Cozza KL, Pimentel PA: Med-Psych Drug-Drug Interactions Update: Immunosuppressants. Psychosomatics 43(5): 424-427, 2002.
Armstrong SC, Cozza KL: Med-Psych Drug-Drug Interactions Update: Triptans. Psychosomatics 43(6): 502-504, 2002.
Armstrong SC, Cozza KL: Med-Psych Drug-Drug Interactions Update: Pharmacokinetic drug interactions of morphine, codeine and their derivatives: theory and clinical reality: Part I. Psychosomatics 44(2): 167-171, 2003
Armstrong SC, Cozza KL, Sandson NB: Med-Psych Drug-Drug Interactions Update: Six Patterns of Drug Interactions. Psychosomatics 44(3): 255-258, 2003
Armstrong SC, Cozza KL: Med-Psych Drug-Drug Interactions Update: Antihistamines. Psychosomatics 44(5):430-434, 2003
Armstrong SC, Cozza KL: Med-Psych Drug-Drug Interactions Update: Pharmacokinetic drug interactions of morphine, codeine and their derivatives: theory and clinical reality: Part II. Psychosomatics 44(6); 515-520, 2003
Oesterheld JO, Armstrong SC, Cozza KL: Med-Psych Drug-Drug Interactions Update: Pharmacokinetic and Pharmacodynamic drug interactions with Ecstasy. Psychosomatics 45(1):84-87, 2004
Wynn GH, Zapor MJ, Smith B, Wortmann G, Oesterheld JH, Armstrong SC, Cozza KL: Med-Psych Drug-Drug Interactions Update: Antiretrovirals, Part I: Overview, History, and Focus on Protease Inhibitors. Psychosomatics 45(3):262-270, 2004
Fireman M, DiMartini AF. Armstrong SC, Cozza KL: Med-Psych Drug-Drug Interactions Update: Immunosuppressants. Psychosomatics 45(4):354-360, 2004
Zapor MJ, Cozza KL, Wynn GH, Wortmann GW, Armstrong SC: Antiretrovirals Part II; Focus on Non-Protease Inhibitor Antiretrovirals (NRTIs, NNRTIs and Fusion Inhibitors). Psychosomatics 45(6);524-535, 2004
Wynn GH, Cozza KL, Zapor MJ, Wortmann GW, Armstrong SC: Antiretrovirals Part III: Antiretrovirals and Drugs of Abuse. Psychosomatics 46(1):79-87, 2005
DeLeon J, Armstrong SC, Cozza, KL: The Dosing of Atypical Antipsychotics. Psychosomatics 46(3):262-273, 2005
Sandson NB, Armstrong SC, Cozza KL: Intrapsychotropic Drug-Drug Interactions. Psychosomatics 46(4):464-494, 2005
DeLeon J, Armstrong SC, Cozza KL: Clinical Guidelines for Pharmacogenetic testing of CYP2D6 and CYP2C19. Psychosomatics 47(1):75-85, 2006
Sandson NB, Cozza KL, Armstrong SC, Eckermann G, Fisher B, Phillips B: Clozapine case series. Psychosomatics 48(2):170-175, 2007
Armstrong SC, Cozza KL, Sandson NB: Pharmacokinetic Drug Interactions of Synthetic Opiate Analgesics. Psychosomatics, 50(2):169-176 2009

Books:

Co-author:

Cozza KL and Armstrong SC: The Concise Guide to the Cytochrome P450 System: Drug Interaction Principles for Medical Practice. Published by the American Psychiatric Publishers, Inc., 2001. (Best selling book for the publisher, APPI, at the Annual APA meetings in 2001 and 2002).

Cozza KL, Armstrong SC and Oesterheld JH: The Concise Guide to Drug Interactions for Medical Practice: Cytochrome P450, UGTs, P-glycoproteins. 2nd Edition. Published by the American Psychiatric Publishers, Inc., 2003 (Best selling book for the publisher, APPI, at the Annual APA meeting in 2003).

PDA version of The Concise Guide to Drug Interactions for Medical Practice, 2005. Available through www.skyscape.com

Cozza KL, Armstrong SC, Oesterheld JH, Sandson NB: Study Guide to Clinical Psychopharmacology, a companion to the American Psychiatric Publishing Textbook of Psychopharmacology, 3rd Edition. Published by the American Psychiatric Publishers, Inc. 2007.

Wynn GH, Cozza KL, Oesterheld JH, Armstrong SC. The Clinical Manual of Drug Interaction Principles in Medical Practice: the P450 System. Published by the American Psychiatric Publishers, Inc. 2009.

Contributor:

Sandson NB: The Drug Interaction Case Book. Contributors: Cozza KL, Armstrong SC, Oesterheld JR. Published by the American Psychiatric Publishers, Inc., 2003.

Sandson NB: Drug-Drug Interaction Primer: A Compendium of Case Vignettes for the Practicing Clinician. Contributors Cozza KL, Armstrong SC, Oesterheld JR. Published by the American Psychiatric Publishers, Inc., 2007.

Book Chapters:

Armstrong SC, Cozza KL, Oesterheld JH, Sandson NB, Wynn GH: Chapter 42, "Overview of Drug Interactions in Psychosomatic Medicine", in textbook: Psychosomatic Medicine, Editors Blumenfield M and Strain JJ, Published by Lippincott, Williams and Wilkins, 2006, pp 767-799.

IX) National/Worldwide Presentations:

1988 Army Menninger Conference: "Psychiatric Readmissions." Topeka, KS.
1991 Army Menninger Conference: "Managed Care at an Army Community Hospital" Topeka, KS.
1993 American Psychiatric Association"s 146th Annual Meeting: Co-directed 6-hour workshop on "Psychiatric Disorders that Mimic Medical Disorders." San Francisco, CA.
1993 U.S. Army's Medical Congress in Germany: presentations on: "New Medications in Psychiatry", "Conversion Disorders" and "The Army's Managed Care/Gateway to Care program." Germany.
1994 American Group Psychotherapy Association's 51st Annual Meeting: presentation and panel discussion on "Debriefing Medical Teams After Disasters: experience in C-130 crash in Alaska, 1989." Washington, DC.
1995 Academy of Psychosomatic Medicine's 42nd Annual Meeting: Paper presentation on "Misdiagnosis of Delirium by Nonpsychiatric House Staff." Pheonix, AZ.
1997 Academy of Psychosomatic Medicine's 44th Annual Meeting: Workshop on "The Cytochrome P450 System for the C-L Psychiatrist." San Diego, CA.
1998 Academy of Psychosomatic Medicine's 45th Annual Meeting: Workshop on "Update on Cytochrome P450 System for the C-L Psychiatrist." Buena Vista, FL.
1999 International Association of Psychosocial Rehabilitation Services 24th Annual Conference. Institute #35, Psychiatric Update, "Armstrong's TOP TEN of Geriatric Psychiatry." Minneapolis, MN.
2000 American Psychiatric Association's 153rd Annual Meeting: Directed 4-hour workshop on "Med-Psych Implications of Cytochrome P450." Chicago, IL.
2001 American Psychiatric Association's 154th Annual Meeting: Co-directed an updated 4-hour workshop on "Med-Psych Implications of Cytochrome P450." New Orleans, LA.
2001 Academy of Psychosomatic Medicine's 48th Annual Meeting: Workshop on "Update on Drug-drug Interactions in the Med-Psych Setting." San Antonio, TX.
2002 American Psychiatric Association's 155th Annual Meeting: Directed 6-hour workshop on "Med-Psych Drug-Drug Interactions." Philadelphia, PA.
2002 Psychiatric Services Institute 45th Annual Meeting: Co-directed 6-hour workshop on "Med-Psych Drug-Drug Interactions." Chicago, IL.
2003 Oregon Family Practice 34th Annual Review: "A Primer for Drug-Drug Interactions." Portland, OR.
2003 Grand Rounds, Dept of Psychiatry, "Update/Review of Med-Psych Drug-Drug Interactions", Beth Israel Hospital, New York, NY
2003 American Psychiatric Association's 156th Annual Meeting: Directed 6-hour workshop on "Med-Psych Drug-Drug Interactions: an update." San Francisco, CA.
2003 Lectured on Med-Psych drug-drug interactions at the 16th Annual Meeting of the Oregon Psychiatric Society, Ashland, OR
2003 Directed a 2-hour workshop at the 50th Annual meeting of the Academy of Psychosomatic Medicine on C-L Drug-Drug Interactions. San Diego, CA.
2004 Lectured at the semiannual German, Swiss, Austrian counsel on adverse drug reactions meeting, AMSP, on concepts of teaching drug-drug interactions, Munich, Germany. Additional lectures on drug-drug interactions given to the departments of Psychiatry at the Universities of Saarland, Mainz and Regensberg, Germany.
2004 Presented for Grand Rounds, Psychiatry Consultation-Liaison Service, on drug-drug interactions, UCLA, Los Angeles, CA.
2004 Co-directed 6-hour workshop on Med-Psych drug-drug interactions at the 157th Annual Meeting of the American Psychiatric Association, New York, NY.
2004 Co-instructor for Psychopharmacology review at the first Psychosomatics Board Review Course/51st Annual Meeting of the Academy of Psychosomatic Medicine, Marco Island, FL.
2005 Co-directed 6-hour workshop on Med-Psych Drug-Drug Interactions at the American Psychiatric Association's 158th Annual Meeting, Atlanta, GA.
2005 Instructor for "Top Ten Issues of Geriatric Psychiatry" and "A Primer on Drug-Drug Interactions" at the 28th Annual Meeting of the Oregon Nurses Association, Seaside, OR.
2005 Co-Instructor for Psychosomatics Update Course on "Critical Aspects of Psychopharmacology" at 52nd Annual Meeting of the Academy of Psychosomatic Medicine, Albuquerque, NM.
2006 Coordinator and Faculty for a workshop, "An Overview of Drug-Drug Interactions in the Elderly" at the Annual Meeting of the American Association of Geriatric Psychiatry, San Juan, PR.
2006 Coordinator and faculty on drug-drug interactions at the Annual Meeting of the Florida Psychiatric Association, Boca Rotan, FL.
2006 Lectured on drug-drug interactions and on clinical issues of geriatric psychiatry at the 7th Annual Meeting of Oregon Geriatric Society/Oregon Medical Director's meeting at Sun River, OR.
2006 Lectured at the 29th Annual Educational Conference of the Oregon Nurses Association on drug-drug interactions at Sun River, OR.
2007 Lectured on the management of behavioral disturbances in dementia at Napa State Hospital Grand Rounds, Napa, CA.
2007 Presented at the Department of Psychiatry, OHSU Grand Rounds on the management of behavioral disturbances in dementia, Portland, OR
2007 Co-instructor for course on a review of pharmacology and drug-drug interactions at the 54th Annual Meeting of the Academy of Psychosomatic Medicine, Amelia Island, FL.
2008 Practical applications of drug interactions in medically complicated patients. At the 35th Annual Winter Meeting of the Oregon Psychiatric Association, Portland, OR.
2008 Co-directed 6-hour workshop at the 161st Annual Meeting of the American Psychiatric Association on drug-drug interactions, Washington, DC.
2009 Co-directed 6-hour workshop at the 162nd Annual Meeting of the American Psychiatric Association on drug-drug interactions, San Francisco, CA.

X) Other Current/recent Professional Activities:

1992-2002. Peer reviewer for Military Medicine
1995-2006. Peer reviewer for Psychosomatics
1999-2006. Editorial Board for the Journal of Psychosomatics
1999-2006. Editor/writer for Psychosomatics column on Med-Psych drug-drug interactions.
2008-current. Treasurer/Secretary for Psychiatry section of the Christian Medical Dental Association